Do the Evolving Methods of TB Diagnosis Benefit Your Business?

For centuries, Tuberculosis (TB) has been a global health challenge. It is an infectious disease caused by some harmful bacteria. It commonly affects human lungs and can also harm other organs such as kidneys, spines, and brain. It is a life-threatening disease that can lead to death if not diagnosed early. The conventional methods of TB diagnosis include sputum microscopy and culture, which usually take two to three weeks. However, continuous advancements in science & technology have brought advanced techniques for detecting TB such as rapid blood tests and various point-of-care diagnostic tools. This article talks about the latest advancements reshaping the TB diagnostic market and the participation of leading players in the industry. 

New TB diagnostics methods and treatment: 

TB is a communicable disease that spreads when a healthy person inhales a cough or sneezes from an infected individual. The persistence of dangerous bacteria inside the human lungs for a long time can cause severe infection. Therefore, early diagnosis and treatment are paramount. Furthermore, the complexity of detecting the risk associated with XDR (extensively drug-resistant) -TB and MDR (multidrug-resistant) -TB evokes researchers to develop rapid TB detection techniques such as biosensing and point-of-care tool kits. With the continuous progress in science and technology, researchers have developed advanced techniques for detecting TB such as molecular diagnostic methods and nano-biosensing technologies. 

Polymerase chain reaction (PCR) and nucleic acid amplification tests (NAATs) are the two methods of diagnosing TB based on molecular diagnostic techniques. These procedures can be beneficial in detecting the genetic composition of “Mycobacterium tuberculosis”, the bacterium causing TB with higher sensitivity and speed. Additionally, GeneXpert has come out as a groundbreaking technology that has redefined molecular diagnostic methods. It is an automated molecular diagnostic tool that can allow rapid TB detection and simultaneously assess drug resistance. This technology takes a few hours to provide results which can be a game-changer in TB diagnostics procedures. On the other hand, artificial intelligence (AI) integration can help enhance the accuracy of medical imaging and X-ray capabilities, aiding in quicker and more precise identification of TB-related abnormalities. 

Growth opportunities in the market: 

The TB diagnostic market is experiencing promising growth owing to the increasing cases of tuberculosis among individuals across the globe. Moreover, the continuous development of robust healthcare infrastructure and the increasing demand for unmet healthcare needs can create extensive growth opportunities for the market. Based on the analysis of the different types of TB diagnoses, the rapid molecular diagnosis segment is expected to lead the trail by garnering a revenue of $543.7 million over the analysis period from 2022 to 2032. Country-wise, Australia is predicted to showcase the highest CAGR of 6.8% over the estimated timeframe. 

Product launches in the industry: 

To cater to the growing demand for rapid detection methods for TB, many leading market players have come up with innovative launches. A notable example is the launch of a rapid test kit, namely “mfloDx MDR-TB by EMPE Diagnostics, a renowned biotechnology company. With this launch, the company aimed to offer a cost-effective, instant, and accurate kit that could indicate the presence of Mycobacterium tuberculosis and its resistance profile. 

Another instance is the launch of a new drug-resistant tuberculosis profiling test, “Xpert® MTB/XDR* test”, by The Foundation for Innovative New Diagnostics and Cepheid, Inc., a leading American molecular diagnostics company. This test can give results in 90 minutes and allows clinicians to prescribe treatment regimens for drug-resistant TB. 

To sum up, the rising geriatric population and the advancements in TB diagnosis are the prime factors that can fuel the market's growth in the upcoming years. Moreover, substantial investments in developing cutting-edge TB diagnostics techniques can create immense opportunities for the market. 

Related Post